Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-10-22-Speech-4-014"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Problem of limited access of developing countries to some vaccines (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20091022.4.4-014"2
lpv:hasSubsequent	lp_eu:2009-10-22-Speech-4-0152
lpv:speaker	lp:Frédérique Ries2
lpv:spokenAs	member; ENVI (2009-07-16--2012-01-18)3 member; Delegation for relations with Israel (2009-09-16--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 unknown; Mouvement Réformateur (2009-07-14--2014-06-30)3 member; FEMM (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3 member; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3 member; ALDE (2009-07-14--2014-06-30)3
lpv:translated text	"Mr President, as we know, this is the week in which most of our Member States are launching the first wave of influenza A vaccinations whilst, at the same time, we are forced to recognise the meagre progress made in this area in terms of access to the vaccine by developing countries. This has just been said: millions of people, and primarily children, die each year in these countries from a whole host of diseases, as was mentioned in particular by my fellow Member, Mr Mitchell, earlier. I am not saying that the solution is simple, especially – not only, but especially – because the question of access to the vaccine is in no way comparable to that of access to medicines, for at least two specific reasons: the small number of producers and control of the refrigeration chain, which is still difficult. There are positive elements, however: the fact that, for the time being, the virus is not mutating and the announced availability of three billion doses each year. These are obvious facts and they demand, they encourage the launching of a strategy on a worldwide scale. In the limited time granted to me, I shall conclude, Mr President, by saying that I therefore think that the European Union must wholeheartedly support the call by the WHO for a fair distribution of vaccines, first and foremost, in the areas of high mortality, and that we must also create the conditions for, and encourage the development of, private and public partnerships so as to effectively combat the shortage of vaccines in the world."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph